Image de couverture de livre

Response to the Commentary on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model”

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	RuoFei Yin, George C. Tseng
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Minding Averages: Comment on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model” by Zong et al.
par: Pål O. Westermark
Publié: (2025)

Weighted Trigonometric Regression for Suboptimal Designs in Circadian Transcriptome Studies
par: Michael T. Gorczyca, et autres
Publié: (2025)

Sample Size Calculation for the ROCI Design
par: Henry Bern, et autres
Publié: (2026)

Integrating Multiple Data Sources With Interactions in Multi‐Omics Using Cooperative Learning
par: Matteo D'Alessandro, et autres
Publié: (2025)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
par: Huiman Barnhart, et autres
Publié: (2025)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
par: Melody A. Owen, et autres
Publié: (2025)

Commentary: Regression Models—Efforts Are Required to Improve Statistical Practice and Teaching
par: Willi Sauerbrei, et autres
Publié: (2025)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
par: Hakim‐Moulay Dehbi, et autres
Publié: (2025)

Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network‐Based Cox Model
par: Jingmao Li, et autres
Publié: (2026)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
par: Abdollah Safari, et autres
Publié: (2026)

Simultaneous Representation Learning of Multi‐Omics and Clinical Outcome Data via a Supervised Knowledge‐Guided Bayesian Factor Model
par: Qiyiwen Zhang, et autres
Publié: (2026)

Rejoinder to Commentaries on: On the Uses and Abuses of Regression Models: A Call for Reform of Statistical Practice and Teaching
par: John B. Carlin, et autres
Publié: (2025)

Integrative Multi‐Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease
par: Yuanyuan Guo, et autres
Publié: (2025)

A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results
par: Rebecca R. Andridge, et autres
Publié: (2025)

To Explain, to Predict, or to Describe: Figuring out the Study Goal [Commentary on “On the Uses and Abuses of Regression Models” by Carlin and Moreno‐Betancur]
par: Galit Shmueli
Publié: (2025)

Extending the Median Odds Ratio ( MOR ), the Interval Odds Ratio ( IOR ), and the Proportion of Opposed Odds Ratios ( POOR ) for Use With 3‐Level Multilevel Logistic Regression Models
par: Peter C. Austin, et autres
Publié: (2026)

A Commentary on Chatterjee Et Al. (2018): A Corrected Framework for Group Sparsity in Zero‐Inflated Negative Binomial Models
par: Adam Iqbal, et autres
Publié: (2025)

Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models
par: Paloma Hauser, et autres
Publié: (2025)

A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
par: Antonio Olivas‐Martinez, et autres
Publié: (2026)

Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs
par: Kunhai Qing, et autres
Publié: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
par: Fei Gao, et autres
Publié: (2025)

A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case‐Crossover Design
par: Yi Shi, et autres
Publié: (2024)

Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection
par: Richard Wyss, et autres
Publié: (2026)

Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
par: Zifei Han, et autres
Publié: (2025)

A Generalized Bayesian Stochastic Block Model for Microbiome Community Detection
par: Kevin C. Lutz, et autres
Publié: (2025)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
par: Guoqiao Wang, et autres
Publié: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
par: Amitay Kamber, et autres
Publié: (2025)

Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift
par: Pai‐Shan Cheng, et autres
Publié: (2026)

Commentary on Fleming et al. “A Perspective on the Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies for Handling Intercurrent Events”
par: Oliver Keene, et autres
Publié: (2026)

Group Response‐Adaptive Randomization With Delayed and Missing Responses
par: Guannan Zhai, et autres
Publié: (2024)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
par: Ryota Ishii, et autres
Publié: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
par: Masahiro Kojima, et autres
Publié: (2026)

Exploring Sensitive Biomarkers Associated With Short‐Term Responses and Long‐Term Outcomes Using Bayesian Additive Regression Trees
par: Zixuan Yao, et autres
Publié: (2026)

Multiple Imputation of Missing Covariates When Using the Fine–Gray Model
par: Edouard F. Bonneville, et autres
Publié: (2025)

Response to Nadarajah
par: Leonhard Held
Publié: (2024)

Joint Bayesian Hidden Markov Model With Subject‐Specific Transitions for Wearable Sensor Data
par: Wenbo Fei, et autres
Publié: (2025)

Flexible and Interpretable Modeling of Overlapping Exposure Risks in Self‐Controlled Case Series Analysis
par: Xuezhixing Zhang, et autres
Publié: (2026)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
par: Adrien Ollier, et autres
Publié: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
par: M. C. Donohue, et autres
Publié: (2025)

Improving the Modeling of Binary Response Regression Based on New Proposals for Statistical Diagnostics With Applications to Medical Data
par: Manuel Galea, et autres
Publié: (2025)